CF Foundation Joins More Than 2,000 CEOs in Commitment to Advance Diversity and Inclusion in the Workplace

CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF

| 3 min read

This month, the Cystic Fibrosis Foundation signed on to the CEO Action for Diversity and Inclusion™ pledge, joining a growing coalition of more than 2,300 signatories across 85 industries in the largest CEO-driven business commitment to advance diversity and inclusion in the workplace. By signing this commitment, the Foundation pledges to take action to cultivate a workplace where diverse perspectives and experiences are welcomed and respected, and where employees feel encouraged to discuss diversity and inclusion. 

“Our commitment to embedding racial justice and DEI principles in all we do is critical to achieving our mission of serving all people with CF and to building and maintaining a strong and inclusive culture and community,” said Michael Boyle, MD, president and CEO of the Cystic Fibrosis Foundation.

 This pledge reaffirms the Foundation’s belief that organizations with diverse teams perform better. By signing the pledge, the Foundation joins a broad coalition in committing to:  

  • Making the organization a trusting place to have complex and sometimes difficult conversations about diversity and inclusion;  
  • Implementing and expanding unconscious bias education; 
  • Sharing successful and unsuccessful practices;  
  • Creating and sharing strategic inclusion and diversity plans with boards and other leaders

This pledge is one of many opportunities the Foundation is pursuing to better address systemic barriers previously neglected, resulting in health disparities for many in the CF community, particularly Black, Hispanic, and other communities of color. Recently, the Foundation formally updated its overall commitment equity, racial justice, diversity and inclusion, reaffirming these themes as core principles guiding the Foundation’s efforts to provide all people with CF the opportunity to live long, fulfilling lives.

Some additional action steps the Foundation has recently taken as part of this effort include:  

  • Providing comments to the U.S. Food and Drug Administration to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials  
  • Publishing the Communities of Color report that details early work to learn and listen from members of the CF community  
  • Forming a Racial Justice Equity and Inclusion Advisory Council to support the Foundation’s efforts to foster an inclusive work environment that is free from discrimination 
  • Convening an External Racial Justice Working Group, a collaboration between Foundation staff and external advisors working to improve health outcomes for and engagement with Black people with CF 

Learn more about the Foundation’s commitment to equity, racial justice, diversity, and inclusion by visiting cff.org.  

Share this article
Topics
About the CF Foundation | Diversity, Equity, and Inclusion
Recent news
FDA Approves Orkambi for Children With CF Ages 1 to 2 Years
News | 3 min read
CF Foundation Celebrates Passage of the Inflation Reduction Act
News | 3 min read
Journal of Cystic Fibrosis Spotlights the Evolving Cystic Fibrosis Care Model
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe